The improved insulin action in the absence of bodyweight change seen in the 4-week treatment of healthy individuals by CL-316,243 (124) suggests that restoration of BAT function may at least lead to improved metabolic control in patients with T2D. Here, INS is linked to type 2 diabetes mellitus.